This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1. PI Tarr , CA Gordon , WL. Chandler Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073–1086.
3. A Ammon , LR Petersen , H. Karch A large outbreak of hemolytic uremic syndrome caused by an unusual sorbitol-fermenting strain of Escherichia coli O157:H. Journal of Infectious Diseases 1999; 179: 1274–1277.
5. JM Rangel , Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982–2002. Emerging Infectious Diseases 2005; 11: 603–609.
9. A Gerber , Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997–2000, in Germany and Austria: a prospective study. Journal of Infectious Diseases 2002; 186: 493–500.
12. M Eklund , Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H− human isolates from Finland. Clinical Microbiology and Infection 2006; 12: 634–641.
13. KA Bettelheim , First isolation outside Europe of sorbitol-fermenting verocytotoxigenic Escherichia coli (VTEC) belonging to O group O157. Journal of Medical Microbiology 2002; 51: 713–714.
14. JH Lee , SJ. Choi Isolation and characteristics of sorbitol-fermenting Escherichia coli O157 strains from cattle. Microbes and Infection 2006; 8: 2021–2026.
16. AW Friedrich , Distribution of the urease gene cluster among and urease activities of enterohemorrhagic Escherichia coli O157 isolates from humans. Journal of Clinical Microbiology 2005; 43: 546–550.
17. M Bielaszewska , Phenotypic and molecular analysis of tellurite resistance among enterohemorrhagic Escherichia coli O157:H7 and sorbitol-fermenting O157:NM clinical isolates. Journal of Clinical Microbiology 2005; 43: 452–454.
20. SB Hunter , Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. Journal of Clinical Microbiology 2005; 43: 1045–1050.
21. M Bitzan , High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. Journal of Pediatrics 1991; 119: 380–385.
22. A Mellmann , Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clinical Infectious Diseases 2005; 41: 785–792.
23. SH Cody , An outbreak of Escherichia coli O157:H7 infection from unpasteurized commercial apple juice. Annals of Internal Medicine 1999; 130: 202–209.
24. CM Taylor , The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome. Pediatric Nephrology 1990; 4: 59–561.
26. S Ethelberg , Virulence factors for hemolytic uremic syndrome, Denmark. Emerging Infectious Diseases 2004; 10: 842–847.
27. D Werber , Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome. European Journal of Clinical Microbiology & Infectious Disease 2003; 22: 726–730.
29. M Bielaszewska , Chromosomal dynamism in progeny of outbreak-related sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM. Applied and Environmental Microbiology 2006; 72: 1900–1909.
30. D Werber , Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groups. American Journal of Epidemiology 2007; 165: 425–434.